LAUSR

Abstract Background  Although electronic medication administration records (eMARs) and bar-coded medication administration (BCMA) have improved medication safety, poor usability of these technologies can increase patient safety risks. Objectives  The objective of our systematic review was to identify the impact of eMAR and BCMA design on usability, operationalized as efficiency, effectiveness, and satisfaction. Methods  We retrieved peer-reviewed journal articles on BCMA and eMAR quantitative usability measures from PsycInfo and MEDLINE (1946–August 20, 2019), and EMBASE (1976–October 23, 2019). Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we screened articles, extracted and categorized data into the usability categories of effectiveness, efficiency, and satisfaction, and evaluated article quality. Results  We identified 1,922 articles and extracted data from 41 articles. Twenty-four articles (58.5%) investigated BCMA only, 10 (24.4%) eMAR only, and seven (17.1%) both BCMA and eMAR. Twenty-four articles (58.5%) measured effectiveness, 8 (19.5%) efficiency, and 17 (41.5%) satisfaction. Study designs included randomized controlled trial ( n  = 1; 2.4%), interrupted time series ( n  = 1; 2.4%), pretest/posttest ( n  = 21; 51.2%), posttest only ( n  = 14; 34.1%), and pretest/posttest and posttest only for different dependent variables ( n  = 4; 9.8%). Data collection occurred through observations ( n  = 19, 46.3%), surveys ( n  = 17, 41.5%), patient safety event reports ( n  = 9, 22.0%), surveillance ( n  = 6, 14.6%), and audits ( n  = 3, 7.3%). Conclusion  Of the 100 measures across the 41 articles, implementing BCMA and/or eMAR broadly resulted in an increase in measures of effectiveness ( n  = 23, 52.3%) and satisfaction ( n  = 28, 62.2%) compared to measures of efficiency ( n  = 3, 27.3%). Future research should focus on eMAR efficiency measures, utilize rigorous study designs, and generate specific design requirements.